Showing results (241-250 of 254) with videos related to
Sort By:
Pageof 26
British Journal of Cancer|October 6, 2011
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary stricturesN S Sandanayake, J Sinclair, F Andreola, et al.Age and Ageing|January 26, 2023
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribedEmily Reeve, Elizabeth A Bayliss, Susan Shetterly, et al.JAMA Network Open|October 3, 2023
Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With DementiaJonathan D Norton, Chan Zeng, Elizabeth A Bayliss, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesionsMichael J Levy, Ian D Norton, Jonathan E Clain, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveformsIan D Norton, Bret T Petersen, Jay Bosco, et al.Gastrointestinal Endoscopy|March 11, 2005
Age-related changes in the pancreas identified by EUS: a prospective evaluationElizabeth Rajan, Jonathan E Clain, Michael J Levy, et al.Journal of Patient Experience|June 22, 2026
Development of a Patient Journey Map for Metabolic Dysfunction-Associated Steatohepatitis: A Comprehensive Assessment of the Patient Journey in North AmericaDavid O Garcia, Roberto A Calle, Abhinav Seth, et al.Pharmacoepidemiology and Drug Safety|April 8, 2025
Discontinuation Categories Underlying Gaps in Dispensing for Six Medication GroupsElizabeth A Bayliss, Glenn K Goodrich, Jennifer C Barrow, et al.JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.Pageof 26